Skip to main content
Premium Trial:

Request an Annual Quote

John Boyce, Stephen Fodor, Jorge Velarde

Premium
John Boyce has left his post as head of business development at Helicos BioSciences to co-found Delphi Bio, a strategic biotechnology consulting firm specializing in the areas of biotechnology tools and consumables. Prior to joining Helicos, Boyce was senior director of commercial development for Parallele Biosciences. He was also senior director of business development for Genomics Collaborative. Before that, he was director for US sales at Sequenom.
 

 
Stephen Fodor plans to step down as CEO of Affymetrix on Jan. 1, the company said last week. Kevin King, Affymetrix’s president, will become CEO and a member of the board of directors. Fodor will remain a full-time executive chairman, a position in which he will “identify and advance new platform technologies and explore new market opportunities for the company,” Affymetrix said in a statement.
 

 
Illumina has promoted Jorge Velarde, Jr. to vice president of business development. Prior to joining Illumina seven years ago, he was a senior manager of business development at Gen-Probe.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more